The Warren Alpert Distinguished Scholars Fellowship Award enables postdoctoral researchers to advance to become full-time faculty members at the Assistant Professor level or higher, and to promote the development of a laboratory program that will lead to independent funding. The Award will support individual postdoctoral scientists of exceptional creativity in the field of neuroscience.
Candidates must have a minimum of 3 years and no more than 6 year of post-doctoral experience by July 1, 2027.

Budget: $200,000/year for 2 years ($400,000 total; inclusive of up to 15% indirect costs)
Nominations Allowed: 1

Key Dates

2027 UTMB Internal RFA

The Ted Nash Long Life Foundation, out of Waco, TX, supports medical research at Qualified Grantee Institutions with the hope that the results of the research will eventually extend the life expectancy of the average American. Research under a Ted Nash Long Life Foundation grant should be conducted under the leadership of a single PI, who is a full-time regular faculty member with tenure or on tenure track. Only 1 “Principal” (PI) is allowed per application. The Foundation intends to fund up to $600,000 total for the FY27 Grant Cycle.

Budget: $100,000 per year for 2 years ($200,000 total; direct costs only, see Internal RFA, lined below, for additional guidelines)
Nominations Allowed: 2

Key Dates

FY27 UTMB Internal RFA

The purpose of the Brain Research Foundation’s Seed Grant is to provide start-up money for new research projects and in the field of neuroscience that will likely lead to extramural funding (NIH or other). The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. BRF Seed Grants are not intended to supplement existing grants.

Each total award is limited to $100,000 (direct costs) for a two-year grant period. The first grant payment of $50,000 will be made upon completion of the Seed Grant Acceptance Form (June 2027). The final payment of $50,000 will be made contingent upon receipt of a Preliminary Progress and Financial Report (June 2028). Funds must be utilized within the grant period. Please see Sponsor Guidelines for additional details regarding allowable costs.

Budget: $50,000/year for 2 years ($100,000 total; direct costs only)
Nominations Allowed: 1

Key Dates

2027 UTMB Internal RFA

Limited Submissions funding opportunities available depend on the given cycle, but are typically released in August each year.

Key Dates
Note: all CPRIT Limited Submissions, with the exception of the RRCTA (see below), have the same key dates

Catalyst Pilot Research Award (CPRA; *formerly High-Impact/High-Risk Research Awards): Supports applications that initiate innovative projects in cancer research or sustain previously funded innovative lines of investigation. Using this mechanism, CPRIT seeks to provide short-term funding to sustain exceptional projects for investigators to start new directions of investigation. Topics include all aspects of cancer research and are expected to contribute to major new insights into etiology, diagnosis, treatment, or prevention of cancer. CPRIT intends to support innovative projects that focus on exceptionally promising topics to ensure they remain competitive for more conventional and longer-term funding. Sponsor RFA
Budget: up to $250,000 in total costs over 2 years
Nominations Allowed: 8
2027 UTMB Internal RFA

Clinical Investigator Award (CIA): The CIA provides protected time (33-50% effort) for midcareer clinician-scientists with specialty training relevant to the delivery of cancer care. Sponsor RFA
Budget: up to $1.5M in total costs for a period of up to 5 years
Nominations Allowed: 2
2027 UTMB Internal RFA

Clinical Trials Network Award (CTNA): The CTNA provides support for Lead Institutions to develop and oversee a network of cancer care facilities, with the goal of developing a statewide clinical trials network. Sponsor RFA
Budget: $500,000 total for up to 5 years
Nominations Allowed: 1
2027 UTMB Internal RFA

Core Facility Support Awards (CFSA): Supports applications that facilitate the development or improvement of core facilities that will provide valuable services to support and enhance scientifically meritorious cancer research projects. CPRIT will look with special favor on applications that propose a facility that will serve cancer researchers at multiple Texas institutions, in particular TREC-eligible institutions. Sponsor RFA
Budget: up to $2M in total costs for a period of up to 5 years
Nominations Allowed: 1
2027 UTMB Internal RFA

Recruitment and Retention of Clinical Trialists (RRCTA): The RRCTA provides support to recruit and retain oncologists to lead cancer therapeutic trials in rural or underserved areas of Texas. Sponsor RFA
Budget: $2-3 M total, depending on career stage
Nominations Allowed: 1 per cycle; 3 per year
2027 UTMB Internal RFA

RRCTA Key Dates:

The Damon Runyon Cancer Research Foundation’s Clinical Investigator Award supports independent early career physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best early career physician-scientists doing work aimed at improving the practice of cancer medicine, and to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments. The applicant must be involved in patient care and be conducting research that has the potential to be translated to impact patients. 
The applicant is required to apply in conjunction with a Mentor. The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels.

Budget: $200,000/year for 3 years ($600,000 total; direct costs only)
Nominations Allowed: 3

Key Dates

2027 UTMB Internal RFA